The Food and Drug Administration on Thursday approved the first daily birth control pill to be sold without a prescription, in a move expected to reduce barriers to accessing contraceptives.
Why it matters: The cost of HRA Pharma’s Opill hasn't been announced, leaving questions around affordability.
